GSK sees blockbuster potential in targeted cancer therapy after promising early data
British drugmaker GSK's experimental targeted cancer drug Mo-rez has blockbuster potential, its head of oncology research has told reporters, after early
April 12, 2026
Nvidia's Jensen Huang says society needs 'new social norms' in the age of AI
Shop offers free ice cream to kids who can recite the Pledge of Allegiance
UN Secretary-General visits Haiti as gang violence soars
Noah Lyles runs a world-best 14.67 seconds to win the 150 meters at Golden Spike meet
G7 leaders call for strong, coordinated response to Ebola outbreak
CNA's 30+ years of care inspires amid nursing shortage
Brewers shortstop prospect Cooper Pratt called up ahead of series with Guardians